STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKANEDIAMINES HAVING ANTI-MULTIDRUG RESISTANT ACTIVITY
STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKANEDIAMINES HAVING ANTI-MULTIDRUG RESISTANT ACTIVITY
批准号:
06672241
负责人:
SAWANISHI Hiroyuki
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
多药耐药是癌症化疗的主要障碍。为了获得有效的多药耐药调节剂,我们合成了一系列末端带有苯、甲基或氯取代苯环的二胺、二羧胺和二磺酰胺类化合物,并研究了它们对长春花碱在耐多药小鼠白血病P388/ADR细胞中蓄积的影响。这些化合物的药效一般为二磺酰胺类、二胺类、二羧胺类。结构上具有末端甲基或氯代苯环的N-甲基二胺和二磺酰胺类化合物也显示出相当强的药效。根据这些发现,我们合成了一种新型的双磺酰胺类化合物1,2,3,4,5,6-六氢-2,5-二(对甲苯磺酰基)苯并[2,5]二氮杂环丙烷,并在体外有效地逆转了该化合物的耐药性。此外,合成了1,3,5-三氮杂环庚烷,并检测了它们对P-糖蛋白依赖的多药耐药性的逆转作用。这些化合物大多能增加耐药小鼠白血病P388/Adr细胞对长春花碱的摄取,但不影响长春花碱在P388/S细胞中的蓄积。1,5-二苄基-1,3,5-三氮杂环庚烷对长春花碱的促进作用顺序为:2,4-二硫代-GT;2-氧-4-硫代=4-(甲硫基)-2,4-二氧代。当将苄基转化为氯苄基时,效果进一步提高。其中,1,5-二(4-氯苯基)-1,5,6,7-四氢-4-甲硫基)-2H-1,3,5-三氮杂-2-酮可增强长春花碱、阿霉素和丝裂霉素C对P388/ADR细胞的体外生长抑制作用,延长P388/ADR荷瘤小鼠的生存时间。
英文摘要
Multidrug resistance is a major obstacle in cancer chemotherapy. To obtain potent multidrug resistance modulators we synthesized a series of diamine, dicarboxamide, and disulfonamide compounds with terminal benzene, methyl- or chloro-substituted benzene rings at both termini and examined the effect on vinblastine accumulation in multidrug-resistant mouse leukemia P388/ADR cells. The efficacy of these compounds was generally in the order of disulfonamides>diamines>dicarboxamides. N-Methylated diamine and disulfonamide compounds having terminal methyl- or chloro-substituted benzene ring in their structure also showed rather potent efficacy. From these findings, we synthesized a novel disulfonamide compound, 1,2,3,4,5,6-hexahydro-2,5-bis (p-toluenesulfonyl) benzo [2,5] diazicine, and this compound potently reversed multidrug-resistance in vitro. Furthermore, 1,3,5-triazacycloheptanes were synthesized and examined for reversal of P-glycoprotein-dependent multidrug resistance. Most of these compounds increased the intracellular uptake of vinblastine in multidrug-resistant mouse leukemia P388/ADR cells without influence upon the vinblastine accumulation in P388/S cells. The efficacy of 1,5-dibenzyl-1,3,5-triazacycloheptanes in increasing the vinblastine accumulation was in the order of 2,4-dithioxo>2-oxo-4-thioxo=4- (methylthio) -2oxo>2,4-dioxo. The efficacy was further increased when the benzyl group was converted to a chlorobenzyl group. Among these compounds, 1,5-bis (4-chlorobenzyl) -1,5,6,7-tetrahydro-4-methylthio ) -2H-1,3,5-triazepin-2-one increased the in vitro cell growth-inhibitory effect of vinblastine, adriamycin, and mitomycin C on P388/ADR cells and prolonged the life span of P388/ADR-bearing mice in combined therapy with vinblastine more than vinblastine alone.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
HIROYUKI,SAWANISHI: "Novel inhibitors for multidrug resistance : 1,3,5-triazacycloheptanes" J Med Chem. 38. 5066-5070 (1995)
HIROYUKI,SAWANISHI:“新型多重耐药抑制剂:1,3,5-三氮杂环庚烷”J Med Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
HIROYUKI,SAWANISHI: "Structure-activity relationships of diamines, dicarboxamides, and disulfonamides on vinblastine accumulation in P388/ADR cells" Chem Pharm Bull. 42. 1459-1462 (1994)
HIROYUKI,SAWANISHI:“二胺、二甲酰胺和二磺酰胺对 P388/ADR 细胞中长春花碱积累的结构活性关系”Chem Pharm Bull。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H. Sawanishi: "Novel inhibitors for moltidrug resistance: 1,3,5-triazacyoloheptanes" J Med Chem. 38. 5066-5070 (1995)
H. Sawanishi:“新型耐药抑制剂:1,3,5-三氮杂环庚烷”J Med Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
HIROYUKI,SAWANISHI: "Structure-activity relationships of diamines,dicarboxamides,and disulfonamides on vinblastine accumulation in P388/ADR cells" Chem Pharm Bull. 42. 1459-1462 (1994)
HIROYUKI,SAWANISHI:“二胺、二甲酰胺和二磺酰胺对 P388/ADR 细胞中长春花碱积累的结构活性关系”Chem Pharm Bull。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Sawanishi: "Structure-activity relationships of diamines,dicarboxamides,and disulfonamides on vinblastine accumulation in P388/ADR cells" Chem.Pharm.Bull. 42. 1459-1462 (1994)
H.Sawanishi:“二胺、二甲酰胺和二磺酰胺对 P388/ADR 细胞中长春花碱积累的结构活性关系”Chem.Pharm.Bull。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Structure-activity relationship of triazacycloalkanes for reversal of antitumor multidrug resistance
-
批准号:08672570
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:SAWANISHI Hiroyuki
-
依托单位:
海外基金